Literature DB >> 6202531

Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action.

N Chand, J Pillar, W Diamantis, J L Perhach, R D Sofia.   

Abstract

Azelastine is a novel, orally effective, long-acting, antiallergic agent. The ability of azelastine to influence calcium ionophore A23187-induced histamine release from rat peritoneal mast cells was investigated and compared with selected antiallergic drugs. The concentrations of drugs required to inhibit A23187 (0.2 microM)-stimulated histamine release by 50% (IC50S, microM) were as follows: azelastine 5; diphenhydramine 52; and ketotifen 200. Theophylline and sodium cromoglycate in a concentration range of 0.1-1000 microM failed to exert any significant inhibition of histamine release. The inhibitory effects of azelastine on A23187-stimulated histamine release were antagonized by high concentrations of exogenous Ca2+ ions. These data suggest that azelastine inhibits A23187-stimulated histamine release by interfering with the influx of Ca2+ into the mast cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6202531     DOI: 10.1016/0014-2999(83)90311-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Inhibitory effects of azelastine on nasal allergic responses in sensitized guinea pigs.

Authors:  H Shirasaki; K Asakura; S Sohma; A Kataura
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.

Authors:  M K Albazzaz; K R Patel
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

3.  A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.

Authors:  C A Gould; S Ollier; R Aurich; R J Davies
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

4.  The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C.

Authors:  E Middleton; P Ferriola; G Drzewiecki; R D Sofia
Journal:  Agents Actions       Date:  1989-08

Review 5.  Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 6.  Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

Authors:  N Chand; J L Perhach; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-03

7.  Modulation of in vitro anaphylaxis of guinea-pig isolated tracheal segments by azelastine, inhibitors of arachidonic acid metabolism and selected antiallergic drugs.

Authors:  N Chand; W Diamantis; R D Sofia
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

8.  Effect of azelastine on sulphur dioxide induced impairment of ciliary motility in airway epithelium.

Authors:  J Tamaoki; A Chiyotani; N Sakai; K Takeyama; K Konno
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

9.  Inhibition of allergic and non-allergic histamine secretion from rat peritoneal mast cells by calcium antagonists.

Authors:  N Chand; W Diamantis; J Pillar; R D Sofia
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

10.  Azelastine and allergen transduction signal in MC9 mast cells.

Authors:  K Fanous; R P Garay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.